Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study.
暂无分享,去创建一个
M. McCarthy | U. Sovio | M. Järvelin | A. Hartikainen | A. Pouta | A. Ruokonen | J. Laitinen | S. Franks | H. Martikainen | S. Taponen | M. McCarthy | M. McCarthy
[1] J. Honour,et al. HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME: CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS , 1989, Clinical endocrinology.
[2] L. Wide,et al. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women , 1994, Clinical endocrinology.
[3] R. Rosenfield. Current concepts of polycystic ovary syndrome. , 1997, Bailliere's clinical obstetrics and gynaecology.
[4] S. Yen,et al. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. , 1970, The Journal of clinical endocrinology and metabolism.
[5] J. Wadsworth,et al. POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.
[6] I. Vauhkonen,et al. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome , 2000 .
[7] I. Vauhkonen,et al. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. , 2000, Human reproduction.
[8] L. Kuller,et al. Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[9] D. Schoenfeld,et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.
[10] S. Franks. POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE , 1989, Clinical endocrinology.
[11] J. L. San Millán,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .
[12] P. Rantakallio,et al. The longitudinal study of the northern Finland birth cohort of 1966. , 1988, Paediatric and perinatal epidemiology.
[13] T. Key,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study* , 2022 .
[14] R. Habershon. Letter: Kumidini hospital. , 1975, Lancet.
[15] B. Çakır,et al. Insulin Resistance in Nonobese Patients with Polycystic Ovary Syndrome , 2001, Hormone Research in Paediatrics.
[16] J. Tapanainen,et al. The prevalence of polycystic ovaries in healthy women , 1999, Acta obstetricia et gynecologica Scandinavica.
[17] M. Knip,et al. Adrenal steroidogenesis is related to insulin in hyperandrogenic women. , 1996, Fertility and sterility.
[18] T. Bützow,et al. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. , 1996, The Journal of clinical endocrinology and metabolism.
[19] S. Franks,et al. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. , 1986, British medical journal.
[20] E. Diamanti-Kandarakis,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.
[21] J. Nestler. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? , 1993, The Journal of clinical endocrinology and metabolism.
[22] A. Lanzone,et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. , 1999, Metabolism: clinical and experimental.
[23] J. Clore,et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. , 1991, The Journal of clinical endocrinology and metabolism.
[24] J. L. San Millán,et al. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. , 2001, European journal of endocrinology.
[25] D. Finegood,et al. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.
[26] H. Yki-Järvinen,et al. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. , 1995, The Journal of clinical endocrinology and metabolism.
[27] K. Segal,et al. Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.
[28] D. Apter,et al. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. , 1995, The Journal of clinical endocrinology and metabolism.
[29] J. Clore,et al. The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome , 1989, American journal of obstetrics and gynecology.
[30] M. Hull. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. , 1987, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[31] B. Corenblum,et al. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. , 2000, Fertility and sterility.
[32] J. Higginson,et al. A prospective study of the prevalence of clear‐cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia , 1994, Clinical endocrinology.